{{Rsnum
|rsid=11774576
|Gene=SCARA5
|Chromosome=8
|position=27882900
|Orientation=plus
|GMAF=0.4605
|Gene_s=SCARA5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 27.4 | 46.0 | 26.5
| HCB | 13.9 | 50.4 | 35.8
| JPT | 10.6 | 51.3 | 38.1
| YRI | 22.4 | 50.3 | 27.2
| ASW | 28.1 | 52.6 | 19.3
| CHB | 13.9 | 50.4 | 35.8
| CHD | 9.2 | 52.3 | 38.5
| GIH | 33.7 | 45.5 | 20.8
| LWK | 28.2 | 48.2 | 23.6
| MEX | 19.0 | 48.3 | 32.8
| MKK | 23.7 | 50.6 | 25.6
| TSI | 38.2 | 43.1 | 18.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=3E-6
  |OR=1.70
  |ORtxt=[1.307-2.208]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}